Sarcoma de Kaposi da conjuntiva — apresentação invulgar de SIDA
Palavras-chave:
SIDA, sarcoma Kaposi ocular, cidofovirResumo
O sarcoma de Kaposi ocular isolado surge em 0,3% a 5% dos doentes com SIDA, mas, em doentes com tumor disseminado, esta incidência aumenta para 15% a 20%.
Apresentamos um caso de sarcoma de Kaposi epidémico, mucocutâneo, cuja primeira manifestação foi ocular. O tratamento inicial consistiu na administração quinzenal de daunorrubicina lipossómica e de anti-retrovíricos. Sob
terapêutica houve progressão da doença, tendo sido a sua regressão conseguida, apenas,
com um esquema alternativo de quimioterapia associada a cidofovir.
Aproveitamos para rever esta entidade, em particular as formas oculares, e discutir a utilização de cidofovir no tratamento do sarcoma de Kaposi associado ao vírus herpes humano tipo 8.
Downloads
Referências
Gottlieb MS, Schroff R, Schanker HM et al. Pneumocystis carinni pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981; 305: 1425-1431.
Masur H, Michelis MA, Greene JB et al. An outbreak of comunity acquired Pneumocystis carinni pneumonia : initial manifestation of cellular immune dysfunction. N Engl J Med 1981; 305: 1431-1438.
Palella FJ, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced Human Immunodeficiency
Virus infection. N Engl J Med 1998; 338: 853-860.
Haverkos H, Drotman D, Morgan M. Prevalence of Kaposi’s Sarcoma among patients with AIDS [letter]. N Engl J Med 1985; 312: 1518.
The swiss HIV cohort study. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy. JAMA 1999;
(23): 2220-2226.
Jabs D, Green W, Fox R, Polk F, Bartlett J. Ocular manifestations of acquired immune deficiency syndrome. Ophthalmol 1989; 96 (7): 1092-
Holland G, Pepose J, Pettit T, Gottlieb M, Yee R, Foos R. Acquired immune deficiency syndrome. Ocular manifestations. Ophthalmol
; 90 (8): 859-873.
Corti M, Solari R, Carolis L, Corraro R. Compromiso ocular en el Sarcoma de Kaposi asociado con el SIDA. Enferm Infecc Microbiol Clin
; 19: 3-6.
Palestine AG, Rodrigues MM, Macher AM et al. Ophthalmic involvement in acquired immune deficiency syndrome. Ophthalmol 1984; 91
(9): 1092-1099.
Shuler J, Holland G, Miles S, Miller B, Grossman I. Kaposi Sarcoma of the conjuntiva and eyelids associated with the acquired immune
deficiency syndrome. Arch Ophthalmol 1989; 107: 858-862.
Cunningham E, Margolis T. Ocular manifestations of HIV infection. N Engl J Med 1998; 339: 236-244.
Collaço L, Gonçalves M, Gomes L, Miranda R. Orbital Kaposi’s Sarcoma in acquired immune deficiency syndrome. Eur J Ophthalmol
; 10 (1): 88-90.
Kurumety U, Lustbader J. Kaposi’s Sarcoma of the bulbar conjuntiva as an initial clinical manifestation of acquired immune deficiency syndrome [letter]. Arch Ophthalmol 1995; 113: 978.
Murray N, McCluskey P, Wakefield D, Beaumont P. Isolated bulbar conjuntival Kaposi’s Sarcoma. Aust N Z J Ophthalmol 1994; 22 (1):
-82.
Kaimbo K. Le sarcome de Kaposi a localisation oculaire au Zaire. BullSoc Belge Ophthalmol 1994 ; 254 : 117-121.
Dugel P, Gill P, Frangieh G, Rao N. Treatment of ocular adnexal Kaposi’s Sarcoma in acquired immune deficiency syndrome. Ophthalmol 1992; 99 (7): 1127-1132.
Dugel P, Gill P, Frangieh G, Rao N. Ocular adnexal Kaposi’s Sarcoma in acquired immune deficiency syndrome. Am J Ophthalmol 1990;
: 500-503.
Dupont C, Vasseur E, Beauchet A et al. Long-term efficacy on Kaposi’sSarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. AIDS 2000; 14 (8): 987-993.
Antman K, Chang Y. Kaposi’s Sarcoma. N Engl J Med 2000; 342: 1027-1038.
Gill PS, Wernz J, Scadden DT et al. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomicin, and vincristine in AIDS-related Kaposi’s Sarcoma. J Clin Oncol 1996; 14: 2353-2364.
Kedes D, Ganem D. Sensitivity of Kaposi’s Sarcoma associated herpes vírus replication to antiviral drugs. J Clin Invest 1997; 99 (9): 2082-
Martin D, Kuppermann B, Wolitz R, Palestine A, Hong Li, Robinson C. Oral ganciclovir for patients with Cytomegalovirus retinitis treated
with a ganciclovir implant. N Engl J Med 1999; 340: 1063-1070.
Robles R, Lugo D, Gee L, Jacobson M. Effect of antiviral drugs used to treat cytomegalovirus end-organ disease on subsequent course of
previously diagnosed Kaposi Sarcoma in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20 (1): 34-38.
Mazzia R, Parisia SG, Sarmatib L et al. Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi’s Sarcoma progression in two
patients with AIDS. AIDS 2001; 15: 2061-2062.
Ficheiros Adicionais
Publicado
Como Citar
Edição
Secção
Licença
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição 4.0.
Direitos de Autor (c) 2023 Medicina Interna
Acesso livre
